Tilray Brands (NASDAQ:TLRY) Shares Up 8% – Here’s Why

Tilray Brands, Inc. (NASDAQ:TLRY) shares were up 8% on Tuesday . The stock traded as high as $6.47 and last traded at $6.47. Approximately 3,592,101 shares traded hands during trading, a decline of 1% from the average daily volume of 3,632,278 shares. The stock had previously closed at $5.99.

Key Stories Impacting Tilray Brands

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Record Q3 revenue beat and strong international cannabis growth — Tilray reported ~ $207M in Q3 revenue (+11% YoY) with international cannabis up ~73%, driving better-than-expected top-line results. GlobeNewswire press release
• Positive Sentiment: Brokerage support: Jefferies reiterated a Buy and kept a lofty $24 price target, citing improving fundamentals and medium-term visibility — this lifts the bull case on execution and upside if margins improve. Proactive Investors
• Positive Sentiment: Roth MKM upgraded TLRY to Buy with a $10 target — another bullish broker move adding conviction to the upside narrative. BayStreet.CA
• Neutral Sentiment: Company reaffirmed FY26 outlook and provided adjusted EBITDA guidance (FY26 $62–$72M) — guidance maintenance reduces near-term execution risk but still leaves questions on cash flow trajectory. Earnings call transcript
• Neutral Sentiment: Analyst divergence: ATB Cormark trimmed its target to $9 and set sector perform — shows mixed sell-side views (some bullish, some cautious). BayStreet.CA
• Negative Sentiment: EPS missed consensus: TLRY reported a $0.24 loss per share vs. an expected $0.14 loss, which pressured sentiment despite the revenue beat. MarketBeat earnings summary
• Negative Sentiment: Margin pressure and negative cash flow persist — analysts note rising competition and beverage segment weakness; adjusted profitability is improving but net margin remains negative. Seeking Alpha analysis
• Negative Sentiment: Some downgrades and lowered expectations (TD Cowen / other shops) hit consensus sentiment after the print, underlining execution and M&A risks that could cap the stock if momentum stalls. AmericanBankingNews

Wall Street Analysts Forecast Growth

TLRY has been the topic of several research reports. ATB Cormark Capital Markets lowered their price objective on shares of Tilray Brands from $9.50 to $9.00 and set a “sector perform” rating on the stock in a research report on Thursday. Roth Mkm raised shares of Tilray Brands from a “neutral” rating to a “buy” rating and set a $10.00 target price for the company in a research report on Thursday. Canaccord Genuity Group began coverage on shares of Tilray Brands in a research note on Tuesday, January 27th. They set a “hold” rating for the company. TD Cowen lowered their price target on shares of Tilray Brands from $10.00 to $7.00 and set a “buy” rating on the stock in a report on Monday. Finally, Wall Street Zen upgraded Tilray Brands from a “sell” rating to a “hold” rating in a research note on Saturday, March 21st. Three research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Tilray Brands currently has an average rating of “Hold” and an average price target of $11.20.

Tilray Brands Trading Up 6.7%

The firm has a fifty day moving average of $7.37 and a two-hundred day moving average of $10.25. The company has a market cap of $763.12 million, a PE ratio of -0.30 and a beta of 1.96. The company has a current ratio of 2.81, a quick ratio of 1.72 and a debt-to-equity ratio of 0.19.

Tilray Brands (NASDAQ:TLRY) last released its quarterly earnings data on Wednesday, April 1st. The company reported ($0.24) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.10). The business had revenue of $206.73 million for the quarter, compared to analysts’ expectations of $201.35 million. Tilray Brands had a negative net margin of 251.69% and a negative return on equity of 6.35%. During the same period last year, the company earned ($0.87) earnings per share. As a group, sell-side analysts predict that Tilray Brands, Inc. will post -0.2 EPS for the current year.

Institutional Trading of Tilray Brands

A number of institutional investors have recently modified their holdings of the business. Silverlake Wealth Management LLC purchased a new position in Tilray Brands in the 3rd quarter valued at approximately $25,000. Oppenheimer & Co. Inc. bought a new position in shares of Tilray Brands in the third quarter worth $25,000. Unified Investment Management purchased a new position in shares of Tilray Brands in the third quarter valued at $26,000. J.W. Cole Advisors Inc. raised its stake in shares of Tilray Brands by 203.2% during the 2nd quarter. J.W. Cole Advisors Inc. now owns 71,890 shares of the company’s stock valued at $30,000 after purchasing an additional 48,177 shares during the period. Finally, Y Intercept Hong Kong Ltd bought a new stake in shares of Tilray Brands during the 3rd quarter valued at $30,000. 9.35% of the stock is currently owned by hedge funds and other institutional investors.

About Tilray Brands

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.